Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

CiToxLAB appointed Alan Bartlett

He becomes senior director of global laboratory operations

- PMLiVE

European women’s health needs people-centred approach, says WHO

Call comes as it develops new health and wellbeing strategy for the region

- PMLiVE

GSK throws gauntlet down to Merck with shingles vaccine data

Shingrix trial reported ninety per cent efficacy in elderly patients who do not respond well to Zostavax

UK flag

UK government tables bill on medicine pricing reforms

New scheme proposes single payment mechanism for old and new drugs alike

- PMLiVE

Global pharma market forecast to reach $1.12tr by 2022

Annual growth of 6.3 per cent expected and biologics are set to occupy a stronger position

- PMLiVE

The Prime Medical Group strengthens leadership team

Karen Turner and Gauri Saal join the comms agency

- PMLiVE

Catherine Allen joins WE Communications

She becomes SVP and general manager of the agency's Boston office

- PMLiVE

Combatting EU drug shortages

New guidelines to be issued after EMA report

Tenth Lucid Academy module delivered – nurturing talent and driving excellence

Celebrating the success of the Lucid Academy

Lucid Group Communications Limited

EISAI

Eisai wins EU licence for kidney cancer drug Kisplyx

Approved as a second-line combination treatment for advanced RCC

Deal Watch August 2016

Pfizer's hat trick as well as Sanofi, GlaxoSmithKline, Boehringer Ingelheim and more are featured in this month's round-up

- PMLiVE

Dept of Health kicks off nationwide sepsis awareness campaign

Hopes to increase public recognition of the condition

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links